166 related articles for article (PubMed ID: 14608100)
1. Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.
Estall JL; Drucker DJ
J Nutr; 2003 Nov; 133(11):3708-11. PubMed ID: 14608100
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 2.
Drucker DJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
[TBL] [Abstract][Full Text] [Related]
4. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
Brubaker PL; Drucker DJ
Endocrinology; 2004 Jun; 145(6):2653-9. PubMed ID: 15044356
[TBL] [Abstract][Full Text] [Related]
5. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
Yusta B; Boushey RP; Drucker DJ
J Biol Chem; 2000 Nov; 275(45):35345-52. PubMed ID: 10940305
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
Boushey RP; Yusta B; Drucker DJ
Cancer Res; 2001 Jan; 61(2):687-93. PubMed ID: 11212269
[TBL] [Abstract][Full Text] [Related]
7. Biological actions and therapeutic potential of the glucagon-like peptides.
Drucker DJ
Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466
[TBL] [Abstract][Full Text] [Related]
8. New frontiers in the biology of GLP-2.
Lovshin J; Drucker DJ
Regul Pept; 2000 Jun; 90(1-3):27-32. PubMed ID: 10828489
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 2 function in domestic animals.
Burrin DG; Stoll B; Guan X
Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
Thulesen J
Curr Protein Pept Sci; 2004 Feb; 5(1):51-65. PubMed ID: 14965320
[TBL] [Abstract][Full Text] [Related]
11. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
[TBL] [Abstract][Full Text] [Related]
12. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
[TBL] [Abstract][Full Text] [Related]
13. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
[TBL] [Abstract][Full Text] [Related]
14. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.
Martin GR; Beck PL; Sigalet DL
World J Gastroenterol; 2006 Jul; 12(26):4117-29. PubMed ID: 16830359
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
18. Glucagon and glucagon-like peptide receptors as drug targets.
Estall JL; Drucker DJ
Curr Pharm Des; 2006; 12(14):1731-50. PubMed ID: 16712485
[TBL] [Abstract][Full Text] [Related]
19. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
Baggio LL; Drucker DJ
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
[TBL] [Abstract][Full Text] [Related]
20. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.
Drucker DJ; Yusta B
Annu Rev Physiol; 2014; 76():561-83. PubMed ID: 24161075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
